Peter Rantis, MD
General Surgery · Hoffman Estates, ILNPI 1306806682
Payments from drug & device makers
What this record shows
This record is dominated by education: $18,000 of the $26,290 with a category attached, or 68.5%. Intuitive Surgical accounts for 85.1% of it on its own, with 37 other manufacturers making up the rest. Reporting peaked in 2019 at $11,055 and has fallen 96.1% since, to $428 in 2025. Among general surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $185.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$22K
- Covidien LP$858
- Medtronic$723
- Teleflex LLC$262
- Mauna Kea Technologies, Inc.$147
- Hologic Sales And Service, LLC$137
- plus $2K from 32 others
What the payments were for
- Travel & lodging$3,95315%
- Food & beverage$4,33716%
- Education$18,00068%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 41 | $22,377 |
| Covidien LP | 10 | $858 |
| Medtronic | 10 | $723 |
| Teleflex LLC | 4 | $262 |
| Mauna Kea Technologies, Inc. | 1 | $147 |
| Hologic Sales And Service, LLC | 6 | $137 |
| Novo Nordisk | 6 | $125 |
| Pacira Pharmaceuticals Incorporated | 4 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $119 |
| Braintree Laboratories, Inc. | 6 | $111 |
| Baxter Healthcare | 1 | $105 |
| Davol Inc. | 1 | $89 |
| Apollo Endosurgery US Inc | 1 | $88 |
| Merck | 5 | $75 |
| Aroa Biosurgery Incorporated | 3 | $69 |
| TELA Bio, Inc. | 4 | $68 |
| Vertex | 3 | $66 |
| W. L. Gore & Associates, Inc. | 3 | $64 |
| Bard Access Systems, Inc. | 1 | $63 |
| Johnson & Johnson | 2 | $56 |
| Axonics, Inc. | 2 | $55 |
| Heron Therapeutics, Inc. | 2 | $54 |
| Palette Life Sciences, Inc. | 2 | $49 |
| Innovation Technologies Inc | 2 | $46 |
| Olympus America Inc. | 2 | $43 |
| Integra Lifesciences Corporation | 2 | $43 |
| Urgo Medical North America, LLC | 1 | $42 |
| Coloplast | 1 | $27 |
| Endo Pharmaceuticals Inc. | 2 | $27 |
| Boston Scientific | 1 | $26 |
| Lilly USA, LLC | 1 | $26 |
| TEI Biosciences Inc | 1 | $22 |
| KCI USA, Inc. | 1 | $21 |
| Innocoll Pharmaceuticals Limited | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Mesh Suture Inc | 1 | $17 |
| Mimedx Group, Inc. | 1 | $16 |
| THD America, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$21,743
- LigaSure$440
- Signia$320
- TITAN SGS BAILOUT CHUCK$184
- Signet$143
- PerClot$105
How this compares
$26,290 in reported general payments places this provider in the 90th percentile of 41 general surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 65 | $4,335 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 14 | $2,248 |
| Omeprazole | 22 | $221 |
| Neomycin Sulfate | 33 | $147 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $77 |
| Metronidazole | 32 | $67 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Braintree Laboratories, Inc.Sutab | $111 | $2,24814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 41 general surgery providers in Illinois.
Other general surgery in Hoffman Estates
- Paul GuskeHoffman Estates$31K
- James KaneHoffman Estates$27K
- Phillip CacioppoElk Grove Village$29K
- Gavish PatelPeoria$10K
- Mark AndersonChicago$365
- Robert GellerMelrose Park$211
- Mohammed ArainDowners Grove$171
- Douglas WisemanChicago$0
- Ciaran BradleyGlen Ellyn$0
- Delinda WillsPeoria$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.